{"id":"W4239471540","doi":"10.2165/00128413-200816250-00072","title":"Rivastigmine patch [Exelon; Novartis] for treating Alzheimer's disease (AD) is now available for use in Canada.","year":2008,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Rivastigmine; Medicine; Disease; Pharmacy; Donepezil; Psychiatry; Dementia; Internal medicine; Family medicine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003076548,0.0003642359,0.0006755016,0.0004478268,0.000590331,0.0005354079,0.0005326203,0.0006248429,0.02416455],"category_scores_gemma":[0.0005923759,0.00009933965,0.0002689458,0.0003840044,0.0002681879,0.0002774897,0.0002548839,0.0009017083,0.007899802],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001169053,"about_ca_system_score_gemma":0.002222212,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03870475,"about_ca_topic_score_gemma":0.08956607,"domain_scores_codex":[0.9998167,0.00002712939,0.00001410946,0.00002080396,0.0000704124,0.00005090838],"domain_scores_gemma":[0.9997429,0.00002781634,0.0000291206,0.00001295978,0.00007632512,0.0001109798],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.007429657,0.0008778059,0.004477047,0.001144771,0.0001739903,0.001969949,0.00006843728,0.0002230741,0.04839418,0.001148864,0.2017687,0.7323235],"study_design_scores_gemma":[0.005096401,0.005154513,0.07343046,0.0003962213,0.0004553037,0.0147979,0.0001874344,0.00115774,0.02891601,0.001132333,0.8691792,0.00009653037],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"commentary","genre_scores_codex":[0.2106883,0.2128055,0.009937221,0.02057062,0.004454782,0.001398993,0.009002457,0.004897366,0.5262448],"genre_scores_gemma":[0.6590338,0.06884452,0.009681591,0.006304267,0.001115371,0.000250553,0.007759415,0.0003577629,0.2466527],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.9612952,"threshold_uncertainty_score":0.0808385,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09349327494708429,"score_gpt":0.3079675040132965,"score_spread":0.2144742290662122,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}